Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The aims of the symposium are to showcase the diversity of current research projects in the IDEU, including those with other collaborators in Oxford, and to facilitate new research collaborations within and beyond Oxford. New Oxford initiatives around global health and antimicrobial resistance will also be presented. This will be a full day symposium with 100 delegates.

This event is hosted by Oxford Population Health and is free-of-charge.

All members of the University are welcome to attend.

Register to attend this event.

Please contact us if you have any questions or comments.

The Infectious Disease Epidemiology Unit Symposium is financially supported by MSD and Azenta.

 

Time

Title

Speaker

09:30 - 09:35 Welcome Angela Brueggemann
Session 1 Chair: Odile Harrison
09:35 - 09:55 Clinical and pathological implications of hepatosplenic schistosomiasis: The SchistoTrack Cohort Goylette Chami
09:55 - 10:15 The ART of antiretroviral treatment in pregnancy Joris Hemelaar 
10:15 - 10:35 The RECOVERY Trial - Beyond COVID-19 Leon Peto
10:35 - 11:00 Tea, coffee and networking
Session 2 Chair: Leon Peto
11:00 - 11:20 Perspectives on the population biology of Neisseria gonorrhoeae Odile Harrison
11:20 - 11:40 Learning from antigen testing for SARS-CoV-2 in the UK David Eyre
11:40 - 12:30 IDEU early- and mid-career researcher short talks
Measuring the impact of the COVID-19 pandemic on invasive bacterial disease: findings from the IRIS Consortium David Shaw
Towards large-scale inference of bacterial ancestral recombination graphs Shing Zhan
An automated pipeline for identifying liver tissue in ultrasound video to support clinical decision making for hepatic schistosomiasis Ellie Ockenden
Care pathways for chronic infectious diseases in rural sub-Saharan Africa: ethical considerations for biomedical research implementation Sandrena Frischer
Determinants of participant attrition and re-joining in SchistoTrack Christin Puthur
Modelling normal physiological responses to infection treatment to enable personalised patient management Qingze Gu
Amoxicillin vs co-amoxiclav for hospital treatment of community-acquired pneumonia Jia Wei
12:30 - 13:15  Lunch and networking
Session 3
13:15- 13:45 IDEU early- and mid-career researcher short talks Chair: Joris Hemelaar
Barcoding Neisseria gonorrhoeae for the discriminative analysis of population structure Anastasia Unitt
High-resolution genomic characterisation of the bacterial pathogen Haemophilus influenzae Krisna Made
Understanding the population structure of Moraxella catarrhalis using core-genome multilocus sequence typing Iman Yassine
A core genome typing tool for Staphylococcus aureus surveillance Nazreen Hadjirin
13:45 - 14:05 Identifying direct risk factors in UK Biobank Helen Fryer
14:05 - 14:25 Nasopharyngeal competition, bacteriocins and vaccines Angela Brueggemann
14:25 - 14:45 Tea, coffee and networking
Session 4 Chair: Angela Brueggemann
14:45 - 15:05 An overview of the MSD Investigator Studies Program and our vaccine research areas of interest

David McIntosh

(industry sponsored session)

15:05 - 15:25 NYC lab bench to global multiomics: Azenta's epic journey

Amy Allwood

(industry sponsored session)

15:25 - 15:45 How can Oxford best contribute in this new era of global health? Alan Bernstein
15:45 - 16:05 The INEOS Oxford Institute Stewart Cole
16:05 - 16:15 Concluding comments Rory Collins

IDEU sponsor MSD logo                                                     Genewiz logo